(19)
(11) EP 4 823 556 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24841536.6

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
A61K 9/51(2006.01)
A61K 47/12(2006.01)
C12N 15/88(2006.01)
A61K 31/713(2006.01)
A61K 47/18(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/5123; A61K 47/12; A61K 47/183; A61K 9/0019; C12N 15/88; A61K 31/713; A61K 31/7105
(86) International application number:
PCT/US2024/059975
(87) International publication number:
WO 2025/128958 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.12.2023 US 202363611075 P

(71) Applicant: ELI LILLY AND CO.
Indianapolis, IN 46285 (US)

(72) Inventors:
  • ESTABROOK, Daniel
    Indianapolis, IN 46285 (US)
  • YU, Zhao
    Indianapolis, IN 46285 (US)
  • HUANG, Lihua
    Indianapolis, IN 46285 (US)
  • WANG, Tingting
    Indianapolis, Indiana 46285 (US)
  • LUCCHESE, Olivia Rose
    Indianapolis, IN 46285 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) STABILIZATION OF LIPID NANOPARTICLE FORMULATIONS